These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26198934)

  • 1. Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis.
    Pfuhl C; Oechtering J; Rasche L; Gieß RM; Behrens JR; Wakonig K; Freitag E; Pache FC; Otto C; Hofmann J; Eberspächer B; Bellmann-Strobl J; Paul F; Ruprecht K
    J Neuroimmunol; 2015 Aug; 285():156-60. PubMed ID: 26198934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
    Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
    J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C; Hofmann J; Ruprecht K
    Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature.
    Ruprecht K; Wildemann B; Jarius S
    J Neurol; 2018 Feb; 265(2):239-252. PubMed ID: 29098417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis.
    Zivadinov R; Ramanathan M; Hagemeier J; Bergsland N; Ramasamy DP; Durfee J; Kolb C; Weinstock-Guttman B
    Mult Scler Relat Disord; 2019 Nov; 36():101388. PubMed ID: 31525628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high-dose vitamin D
    Røsjø E; Lossius A; Abdelmagid N; Lindstrøm JC; Kampman MT; Jørgensen L; Sundström P; Olsson T; Steffensen LH; Torkildsen Ø; Holmøy T
    Mult Scler; 2017 Mar; 23(3):395-402. PubMed ID: 27325604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
    Jafari N; van Nierop GP; Verjans GM; Osterhaus AD; Middeldorp JM; Hintzen RQ
    J Clin Virol; 2010 Sep; 49(1):26-31. PubMed ID: 20638898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Castellazzi M; Tamborino C; Cani A; Negri E; Baldi E; Seraceni S; Tola MR; Granieri E; Contini C; Fainardi E
    Mult Scler; 2010 Jul; 16(7):883-7. PubMed ID: 20483883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins.
    Dooley MM; de Gannes SL; Fu KA; Lindsey JW
    J Neuroimmunol; 2016 Oct; 299():147-151. PubMed ID: 27725113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis.
    Otto C; Oltmann A; Stein A; Frenzel K; Schroeter J; Habbel P; Gärtner B; Hofmann J; Ruprecht K
    Neurology; 2011 Apr; 76(15):1316-21. PubMed ID: 21482946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.
    Sisay S; Lopez-Lozano L; Mickunas M; Quiroga-Fernández A; Palace J; Warnes G; Alvarez-Lafuente R; Dua P; Meier UC
    J Neuroimmunol; 2017 May; 306():40-45. PubMed ID: 28385186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.
    Simpson S; Taylor B; Dwyer DE; Taylor J; Blizzard L; Ponsonby AL; Pittas F; Dwyer T; van der Mei I
    Mult Scler; 2012 Jun; 18(6):799-806. PubMed ID: 22084489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
    Wang Z; Kennedy PG; Dupree C; Wang M; Lee C; Pointon T; Langford TD; Graner MW; Yu X
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):567-580. PubMed ID: 32808238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis and Epstein-Barr virus.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
    Kvistad S; Myhr KM; Holmøy T; Bakke S; Beiske AG; Bjerve KS; Hovdal H; Løken-Amsrud KI; Lilleås F; Midgard R; Njølstad G; Pedersen T; Benth JŠ; Wergeland S; Torkildsen O
    Mult Scler; 2014 Dec; 20(14):1833-40. PubMed ID: 24842958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
    Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M
    Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients.
    Villegas E; Santiago O; Carrillo JA; Sorlózano A; Guerrero M; Fernández O; Gutiérrez J
    Diagn Microbiol Infect Dis; 2011 May; 70(1):85-90. PubMed ID: 21388770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosis.
    Lie IA; Rød BE; Kvistad SS; Holmøy T; Myhr KM; Torkildsen Ø; Wergeland S
    Mult Scler Relat Disord; 2023 Feb; 70():104530. PubMed ID: 36701908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
    Gieß RM; Pfuhl C; Behrens JR; Rasche L; Freitag E; Khalighy N; Otto C; Wuerfel J; Brandt AU; Hofmann J; Eberspächer B; Bellmann-Strobl J; Paul F; Ruprecht K
    PLoS One; 2017; 12(4):e0175279. PubMed ID: 28388676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.